In this webinar, we are discussing the National Medicines Policy (NMP) Review with CHF members, consumer representatives and stakeholders who have an interest in health consumer affairs. The NMP is intended to deliver positive health outcomes for all Australians through access to and appropriate use of medicines.
The Review of the NMP has been commissioned by the Australian Government in recognition of the substantial changes to the health landscape since the policy was published in 2000. It will be high-level and aimed at identifying gaps in the NMP’s objectives, partnership approach and accountabilities.
The Minister for Health, Hon Greg Hunt has established an Expert Advisory Committee to lead the Review for the Department of Health.
Hear from the Committee chair, Deputy Chief Medical Officer, Professor Michael Kidd AM and the Consumer Advisor, Jan Donovan, who is also a member of CHF Board.
They will be joined by: Liz de Somer, CEO, Medicines Australia
For more about the consultation and the review [ Ссылка ]
